KR100948517B1 - Cosmetic Soap Containing Chlorella Extract - Google Patents
Cosmetic Soap Containing Chlorella Extract Download PDFInfo
- Publication number
- KR100948517B1 KR100948517B1 KR1020080036672A KR20080036672A KR100948517B1 KR 100948517 B1 KR100948517 B1 KR 100948517B1 KR 1020080036672 A KR1020080036672 A KR 1020080036672A KR 20080036672 A KR20080036672 A KR 20080036672A KR 100948517 B1 KR100948517 B1 KR 100948517B1
- Authority
- KR
- South Korea
- Prior art keywords
- chlorella
- cosmetic soap
- extract
- supernatant
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000195649 Chlorella <Chlorellales> Species 0.000 title claims abstract description 92
- 239000000344 soap Substances 0.000 title claims abstract description 49
- 239000000284 extract Substances 0.000 title claims abstract description 30
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 48
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 239000013505 freshwater Substances 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 18
- 238000005119 centrifugation Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 7
- 206010003645 Atopy Diseases 0.000 claims description 7
- 206010000496 acne Diseases 0.000 claims description 7
- 230000003020 moisturizing effect Effects 0.000 claims description 6
- 230000002087 whitening effect Effects 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 abstract description 8
- 238000005406 washing Methods 0.000 abstract description 6
- 238000002203 pretreatment Methods 0.000 abstract description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 102000003425 Tyrosinase Human genes 0.000 description 11
- 108060008724 Tyrosinase Proteins 0.000 description 11
- 229930002875 chlorophyll Natural products 0.000 description 10
- 235000019804 chlorophyll Nutrition 0.000 description 10
- 239000000469 ethanolic extract Substances 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 239000000523 sample Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000003796 beauty Effects 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000195628 Chlorophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000629562 Klebsiella aerogenes KCTC 2190 Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D9/00—Compositions of detergents based essentially on soap
- C11D9/04—Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
- C11D9/22—Organic compounds, e.g. vitamins
- C11D9/38—Products in which the composition is not well defined
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
본 발명은 클로렐라 추출물을 함유하는 미용비누에 관한 것으로, 더욱 상세하게는 (1) 액상 클로렐라를 담수로 세척한 후, 40%-50% 에탄올 용액으로 세척하는 전처리 단계: 및 (2) 상기 (1) 단계의 전처리한 클로렐라로부터 유기용매를 첨가하여 유용성분을 추출하는 단계를 포함하는 클로렐라 추출 방법에 의해 수득된 클로렐라 추출물을 함유하는 미용비누 조성물, 상기 미용비누 조성물을 5~20% 첨가하여 제조된 클로렐라 추출물을 함유하는 미용비누에 관한 것이다.The present invention relates to a cosmetic soap containing chlorella extract, and more particularly, (1) pre-treatment step of washing liquid chlorella with fresh water, followed by washing with 40% -50% ethanol solution: and (2) (1) Cosmetic soap composition containing the chlorella extract obtained by the chlorella extraction method comprising the step of extracting the useful component by adding an organic solvent from the pre-treated chlorella of step) prepared by adding 5 to 20% of the cosmetic soap composition It relates to a cosmetic soap containing chlorella extract.
클로렐라, 비누, 유기용매, 추출 Chlorella, Soap, Organic Solvent, Extract
Description
본 발명은 클로렐라 추출물을 함유하는 미용비누에 관한 것이다.The present invention relates to a cosmetic soap containing chlorella extract.
클로렐라는 잘 알려져 있는 단세포 녹조류(Green algae)로서 일반식물의 생리와 같이 광합성에 의하여 탄소원(공기중의 이산화탄소)과 질소, 기타 무기염류를 동화하여 신속히 자기세포의 증식(분열)을 일으키는 유력한 녹조류이다. 이 세포는 단백질, 지방, 기타 유효성분을 다량 함유하므로 유기자원으로 중요하며, 앞으로의 단백질, 지방자원으로 주목받을 수 있는 물질이다. 또한, 이미 산업계에서는 단백질과 엽록소가 풍부하고 특수한 생리작용 인자 및 인체에 유익한 비타민, 미네랄 등을 골고루 함유하고 있는 특성 때문에 건강식품으로 판매하고 있으며, 그외 사료원료, 식품 풍미개선제 등으로 널리 이용되고 있다. 실제 클로렐라의 조제성분은 조류의 종류, 배양방법 및 조건에 따라 다르나 단백질 50~60%, 지방 10~30%, 탄수화물 10~25%, 회분 6~10%로 구성되어 있고 비타민류 및 아미노산 조성등에 있어서도 영양학적으로 우수한 것으로 평가되고 있다. 한편, 균체를 싸고 있는 세포막은 효모보다 두껍고 단단하나 건조법이나 용출법으로 소화율을 올릴 수 있다.Chlorella, a well-known green algae, is a potent green algae that rapidly assimilates carbon sources (carbon dioxide in the air), nitrogen, and other inorganic salts by photosynthesis, such as the physiology of general plants, to rapidly proliferate (dividing) their cells. . These cells contain a large amount of protein, fat, and other active ingredients, so they are important as organic resources. In addition, the industry is already rich in protein and chlorophyll, and contains special physiological action factors and vitamins and minerals that are beneficial to the human body. Therefore, they are sold as health foods, and are widely used as feed ingredients and food flavor improvers. . Actual ingredients of chlorella vary depending on the type of algae, cultivation method and conditions, but are composed of 50 ~ 60% protein, 10 ~ 30% fat, 10 ~ 25% carbohydrate, and 6 ~ 10% ash. It is also evaluated to be nutritionally excellent. On the other hand, the cell membrane surrounding the cell is thicker and harder than yeast, but the digestibility can be increased by drying or elution.
한편, 일반적으로 피부는 땀구멍을 통하여 체내의 노폐물을 배출시키는 기능과 모공을 통하여 피지가 분비되어 수분 증발 방지와 피부의 부드러움을 유지시켜준다. 이러한 노폐물을 효과적으로 제거하기 위하여 비누를 사용하는 것이 일반적인데, 기존의 비누는 단순히 노폐물을 제거하는데 사용되는 것을 목적으로 제조된 것이나 피부에 여러 가지 트러블이 발생한 경우에 효과적으로 이용되지 못하고 있는 것이 현 실정이다.On the other hand, in general, the skin is discharged sebum through the pores through the pores and sebum is secreted through the pores to prevent moisture evaporation and maintain the softness of the skin. It is common to use soap to effectively remove these wastes, and existing soaps are manufactured for the purpose of simply removing wastes, but are not effectively used when various problems occur on the skin. .
일반적으로 피부에 발생하는 트러블은 공기 중의 미생물이 땀과 피지가 많이 분비되는 곳에 기생하게 되어 피부의 염증, 가려움증 및 악취 등이 유발함이 그 원인이 된다. 이에 따라 종래의 보통비누는 피부에 부착된 오물을 제거하여 세균으로부터 피부를 보호하는 역할을 하며, 피부를 세척 및 소독하는 작용을 하는 것이 그 목적이었는데 반하여 상기한 바와 같이 여러 가지 피부 트러블을 해결하기 위하여 새로운 비누의 제조가 필요하기에 이르렀다.In general, the trouble that occurs on the skin is caused by the microbes in the air parasitic where sweat and sebum secreted a lot, causing inflammation, itching and odor of the skin. Accordingly, conventional soaps serve to protect the skin from bacteria by removing dirt attached to the skin, and to clean and disinfect the skin, but to solve various skin problems as described above. In order to produce a new soap has come.
본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명은 클로렐라를 전처리하여 두꺼운 세포벽을 느슨하게 하여 세포내 유용물질인 클로로필 a, 클로로필 b 및 베타 카로틴 등의 용출을 용이하게 하는 방법으로 추출한 클로렐라 추출물을 함유하는 미용비누 조성물을 제공하고, 이 조성물을 첨가하여 제조된 미용비누를 제공함으로써 보습력이 뛰어나고, 여드름을 완화시키며, 아토피 피부를 진정시키는 효과적인 미용비누를 제공하고자 한다.The present invention has been made in accordance with the requirements as described above, the present invention is a chlorella extract extracted by a method of pretreatment of chlorella to loosen the thick cell wall to facilitate the elution of chlorophyll a, chlorophyll b and beta carotene such as intracellular useful substances To provide a cosmetic soap composition containing, and to provide a cosmetic soap prepared by adding this composition to provide an excellent beauty soap moisturizing, relieve acne, soothing atopic skin.
상기 과제를 해결하기 위해, 본 발명은 (1) 액상 클로렐라를 담수로 세척한 후, 40%-50% 에탄올 용액으로 세척하는 전처리 단계: 및 (2) 상기 (1)단계의 전처리한 클로렐라로부터 유기용매를 첨가하여 유용성분을 추출하는 단계를 포함하는 클로렐라 추출 방법에 의해 수득된 클로렐라 추출물을 함유하는 미용비누 조성물을 제공한다.In order to solve the above problems, the present invention (1) pre-treatment step of washing the liquid chlorella with fresh water, then washed with 40% -50% ethanol solution: and (2) organic from the pre-treated chlorella of step (1) It provides a cosmetic soap composition containing a chlorella extract obtained by a chlorella extraction method comprising the step of adding a solvent to extract the useful ingredient.
본 발명은 또한, 상기 미용비누 조성물을 5~20% 첨가하여 제조된 클로렐라 추출물을 함유하는 미용비누를 제공한다.The present invention also provides a cosmetic soap containing chlorella extract prepared by adding 5 to 20% of the cosmetic soap composition.
본 발명은 클로렐라 추출물을 함유하는 미용비누 조성물이 첨가된 미용비누를 제공함으로써 보습력이 뛰어나고, 여드름을 완화시키며, 아토피 피부를 진정시키는 효과적인 미용비누를 제공할 수 있다.The present invention can provide an effective beauty soap that provides excellent moisturizing power, relieves acne, and soothes atopic skin by providing a cosmetic soap containing a cosmetic soap composition containing chlorella extract.
본 발명의 목적을 달성하기 위하여, 본 발명은 (1) 액상 클로렐라를 담수로 세척한 후, 40%-50% 에탄올 용액으로 세척하는 전처리 단계: 및 (2) 상기 (1)단계의 전처리한 클로렐라로부터 유기용매를 첨가하여 유용성분을 추출하는 단계를 포함하는 클로렐라 추출 방법에 의해 수득된 클로렐라 추출물을 함유하는 미용비누 조성물을 제공한다.In order to achieve the object of the present invention, the present invention is a pretreatment step of washing (1) liquid chlorella with fresh water, and then 40% -50% ethanol solution: and (2) the pretreated chlorella of step (1) It provides a cosmetic soap composition containing a chlorella extract obtained by a chlorella extraction method comprising the step of extracting a useful ingredient by adding an organic solvent from the.
본 발명의 일 구현예에 따른 조성물의 전처리 단계는 (a) 액상 클로렐라에 깨끗한 담수를 1:1 중량비로 넣은 후 원심분리하여 상층액을 제거하여 농축하는 방법을 3회 반복 실시하는 단계; (b) (a)단계의 클로렐라에 40%-50%의 에탄올 용액을 1:1 중량비로 넣어 혼합한 후 원심분리하여 상층액을 제거하여 농축하는 방법으로 2회 반복 실시하는 단계; 및 (c) (b)단계의 클로렐라에 40%-50%의 에탄올 용액을 1:1 중량비로 넣어 혼합한 후 원심분리하여 상층액을 제거하고 클로렐라 페이스트만을 회수하는 단계로 이루어진다.The pretreatment step of the composition according to an embodiment of the present invention comprises the steps of (a) repeating the method of removing and concentrating the supernatant by centrifugation after putting clean fresh water in a liquid chlorella in a 1: 1 weight ratio; (b) adding 40% -50% ethanol solution to the chlorella of step (a) in a 1: 1 weight ratio, followed by centrifugation to remove the supernatant and concentrating twice; And (c) 40% -50% ethanol solution in a 1: 1 weight ratio of chlorella in step (b), followed by centrifugation to remove the supernatant and recovering only chlorella paste.
본 발명의 일 구현예에 따른 전처리한 클로렐라로부터 유기용매를 첨가하여 유용성분을 추출하는 단계는 (a) 전처리한 클로렐라 페이스트에 95% 이상의 에탄올을 1:10 중량비로 넣고 3-4시간 동안 교반기를 이용하여 혼합한 후 원심분리하여 상등액과 클로렐라 페이스트로 분리하는 단계; (b) 상기 분리된 클로렐라 페이스트에 95% 이상의 에탄올을 1:10 중량비로 넣고 3-4시간 동안 교반기를 이용하여 혼합한 후 원심분리하여 상등액과 클로렐라 페이스트로 분리하는 단계; 및 (c) 상기 (a)단계 및 (b)단계의 상등액을 회수하는 단계로 이루어진다. 상기 에탄올은 95% 이상, 바람직하게는 95%이다. 본 발명의 전처리한 클로렐라 페이스트로부터 유기용매를 첨가하여 유용성분을 추출하는 단계는 2회 반복 실시하였으나, 본 발명의 효과를 달성할 수 있는 범위 내에서 추가적으로 반복 실시할 수 있다.Extracting the useful component by adding an organic solvent from the pretreated chlorella according to one embodiment of the present invention comprises (a) adding at least 95% ethanol in a 1:10 weight ratio to the pretreated chlorella paste for 3-4 hours. Mixing by using a centrifugation to separate the supernatant and chlorella paste; (b) adding 95% or more of ethanol in a 1:10 weight ratio to the separated chlorella paste, mixing the mixture for 3-4 hours using a stirrer, and centrifuging to separate the supernatant and chlorella paste; And (c) recovering the supernatant of steps (a) and (b). The ethanol is at least 95%, preferably 95%. Extracting the useful component by adding an organic solvent from the pretreated chlorella paste of the present invention was performed twice, but may be additionally repeated within the range to achieve the effect of the present invention.
본 발명의 일 구현예에 따른 클로렐라 추출물은 항균 활성, 용혈활성 및 미백효과를 나타내는 것을 특징으로 한다. 클로렐라 추출물의 비브리오 파라헤모리티쿠스 KCTC2471 (Vibrio parahaemolyticus KCTC2471)과 에드워드 타르다 NUF251 (Edward tarda NUF251)에 대한 최소저해농도(MIC)와 최소살균농도(MBC)는 각각 125 ㎍/mL, 250 ㎍/mL으로 두 균주에서 같은 활성을 나타내었다. 클로렐라 추출물의 용혈활성은 1.0 mg/mL 클로렐라 추출물에서 3%로 확인되었다. 클로렐라 에탄올 추출물의 티로시나제 (tyrosinase) 저해 활성 IC50는 10.87 mg/mL로 나타났다.Chlorella extract according to one embodiment of the present invention is characterized by exhibiting antibacterial activity, hemolytic activity and whitening effect. Chlorella extract of H. Emory V. Para Ti Syracuse KCTC2471 (Vibrio parahaemolyticus KCTC2471) and Edward tar is NUF251 (minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for Edward tarda NUF251) showed 125 ㎍ / mL, activity of the two strains to 250 ㎍ / mL, respectively. The hemolytic activity of chlorella extract was found to be 3% in 1.0 mg / mL chlorella extract. The tyrosinase inhibitory activity IC 50 of chlorella ethanol extract was found to be 10.87 mg / mL.
본 발명은 상기 미용비누 조성물을 5~20 중량% 첨가하여 제조된 클로렐라 추출물을 함유하는 미용비누를 제조한다. 바람직하게는 20 중량%를 첨가한다. 본 발명에 따른 클로렐라 추출물을 함유하는 미용비누를 제조하는데 일반적으로 잘 알려져 있는 에센스 및 향료를 첨가하여 제조할 수 있고, 통상의 방법으로 압축성형하여 비누를 제조할 수 있다.The present invention prepares a cosmetic soap containing chlorella extract prepared by adding 5 to 20% by weight of the cosmetic soap composition. Preferably 20 wt% is added. To prepare a cosmetic soap containing chlorella extract according to the present invention can be prepared by the addition of essences and fragrances which are generally well known, and can be prepared by compression molding in a conventional manner.
본 발명의 일 구현예에 따른 미용비누는 보습효과, 여드름 완화 효과 및 아토피 완화 효과가 있는 것을 특징으로 한다.Beauty soap according to one embodiment of the present invention is characterized by having a moisturizing effect, acne relief effect and atopy relief effect.
이하, 본 발명을 실시 예에 의해 상세히 설명한다. 단, 하기 실시 예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시 예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.
실험방법Experiment method
<1. 클로렐라 유기용매 추출을 위한 클로렐라 전처리><1. Chlorella Pretreatment for Chlorella Organic Solvent Extraction>
① 담수세척① Freshwater Wash
클로렐라로부터 불순물을 제거하기 위해 농축된 액상 클로렐라((주)클로랜드)에 깨끗한 담수를 1:1 중량비로 넣은 후 원심분리하여 상층액을 제거하는 방법으로 3회 반복 실시한다.In order to remove impurities from chlorella, clean fresh water is added to the concentrated liquid chlorella Co., Ltd. at a weight ratio of 1: 1, and then centrifuged to remove the supernatant.
② 에탄올 용액 세척② Wash ethanol solution
담수로 3회 세척한 클로렐라 농축액에 50%의 에탄올 용액을 1:1 중량비로 넣어 혼합한 다음 원심분리하여 상층액을 제거하는 방법으로 2회 반복 실시한다.50% ethanol solution was mixed in a 1: 1 weight ratio to the chlorella concentrate washed three times with fresh water, followed by centrifugation to remove the supernatant.
③ 2차 에탄올 용액 세척③ Second ethanol solution washing
상기 ①, ②의 방법으로 총 5회 세척한 클로렐라 페이스트에 50%의 에탄올 용액을 1:1 중량비로 넣어 혼합한 다음 원심분리하여 상층액을 제거하고 클로렐라 페이스트만을 회수한다.50% ethanol solution was mixed in a 1: 1 weight ratio to the chlorella paste washed five times by the method of ① and ②, followed by centrifugation to remove the supernatant and recover only chlorella paste.
<2. 클로렐라 유기용매 추출><2. Chlorella Organic Solvent Extraction>
① 1차 에탄올 용액 추출① Extraction of Primary Ethanol Solution
상기 실험방법 1의 ③에서 회수한 클로렐라 페이스트에 95% 에탄올을 1:10 중량비로 넣고 약 3-4시간 동안 교반기를 이용하여 혼합한 후 원심분리하여 상등액 을 회수한다. 95% ethanol was added in a 1:10 weight ratio to the chlorella paste recovered in ③ of Experimental Method 1, and mixed with a stirrer for about 3-4 hours, followed by centrifugation to recover the supernatant.
② 2차 에탄올 용액 추출② Extraction of Second Ethanol Solution
상기 ①의 1차 에탄올 추출과정에서 회수된 클로렐라 페이스트에 95% 에탄올을 1:10 중량비로 넣고 약 3-4시간 동안 교반기를 이용하여 혼합한 후 원심분리한 후 상등액을 회수한다.95% ethanol is added in a 1:10 weight ratio to the chlorella paste recovered in the first ethanol extraction process of ① and mixed using a stirrer for about 3-4 hours, followed by centrifugation to recover the supernatant.
<3. 추출된 클로렐라의 유용 성분의 분석><3. Analysis of Useful Components of Extracted Chlorella>
HPLC(Acme 9000 & Nanospace SI-2, Korea)를 사용하여 엽록소(chlorophyll)를 분석하였다. 양성 대조구(positive control)로 광주과기원에서 분리한 순도 90% 엽록소(chlorophyll)을 사용하였다. HPLC(Acme 9000 & Nanospace SI-2, Korea)를 이용한 추출조건은 다음과 같다. 컬럼은 Capcell-Pak C18 (4.6×250 mm : Shiseido Co. Ltd, Japan)를 사용하였고, 주입량(Injection volume)은 20 uL, 유속은(Flow rate)은 1.0 mL/min, 파장(Wavelength)은 450 nm, 용매(Mobile Phase)는 MeOH : DCM : CH3CN : H2O(67.5: 22.5: 9.5: 0.5)를 이용하여 상온에서 수행하였다.Chlorophyll was analyzed using HPLC (Acme 9000 & Nanospace SI-2, Korea). As a positive control, purity 90% chlorophyll isolated from Gwangju Institute of Science was used. Extraction conditions using HPLC (Acme 9000 & Nanospace SI-2, Korea) are as follows. Capcell-Pak C18 (4.6 × 250 mm: Shiseido Co. Ltd, Japan) was used for the column, the injection volume was 20 uL, the flow rate was 1.0 mL / min, and the wavelength was 450 nm, a solvent (Mobile Phase) was performed at room temperature using MeOH: DCM: CH 3 CN: H 2 O (67.5: 22.5: 9.5: 0.5).
<4. 추출된 클로렐라의 유용 성분의 활성 분석><4. Activity Analysis of Useful Components of Extracted Chlorella>
① 항균 활성① antimicrobial activity
클로렐라의 최소저해농도 (minimal inhibitory concentration, MIC)와 최소살균농도 (minimal bacteriocidal concentration, MBC)를 조사하기 위해 그람 양성 박테리아(Gram-positive bacteria)로서 바실러스 서브틸리스 PM125 ( Bacillus subtilis PM125), 바실러스 리케니포르미스 (Bacillus licheniformis ), 마이크로코 커스 루테우스 KCT0C1056 ( Microccus luteus KCT0C1056) 및 스타필로코커스 아우레우스 KCTC1916 (Staphylococcus aureus KCTC1916) 등을 사용하였고, 그람-음성 박테리아(gram-negative bacteria)로는 에세리키아 콜리 D31 (Escherichia coli D31), 에세리키아 콜리 KCTC1184 (Escherichia coli KCTC1184), 엔테로박터 에로진 스 KCTC2190(Enterobacter aerogenes KCTC2190), 클렙시엘라 뉴모니애 KCTC 2208(Klebsiella pneumoniae KCTC 2208), 슈도모나스 에루지노사 KCTC2004 ( Pseudomonas aeruginosa KCTC2004) 및 살모넬라 타이피뮤리움 KCTC 1925 (Salmonella typhimurium KCTC 1925)를 사용하였으며, 어병 세균으로는 비브리오 파라헤모리티쿠스 KCTC2471 (Vibrio parahaemolyticus KCTC2471)과 에드워드 타르다 NUF251 (Edward tarda NUF251)을 사용하였다. As Gram-positive bacteria to investigate chlorella's minimal inhibitory concentration (MIC) and minimal bacteriocidal concentration (MBC) Bacillus Subtilis PM125 ( Bacillus subtilis PM125), Bacillus Rickenio Formis ( Bacillus) licheniformis), microcode Caicos Lou Proteus KCT0C1056 (Microccus luteus KCT0C1056) and Staphylococcus Aureus KCTC1916 ( Staphylococcus aureus KCTC1916), etc., and Escherichia as gram-negative bacteria . Collie D31 ( Escherichia coli D31), Esseria Collie KCTC1184 ( Escherichia coli KCTC1184), Enterobacter erotic Jean's KCTC2190 (Enterobacter aerogenes KCTC2190), Klebsiella Pneumoniae KCTC 2208 (Klebsiella pneumoniae KCTC 2208) , luge Pseudomonas labor KCTC2004 (Pseudomonas aeruginosa KCTC2004) and S. typhimurium KCTC 1925 was used (Salmonella typhimurium KCTC 1925), Fish Pathology bacteria is Vibrio para H. Emory Tea Syracuse KCTC2471 ( Vibrio parahaemolyticus KCTC2471) and Edward Tarda NUF251 ( Edward tarda NUF251) was used.
② 항곰팡이 활성② antifungal activity
항곰팡이의 활성 측정은 액체 성장 분석 방법(liquid growth assay method)으로 측정하였다. 칸디다 알비칸스 KCTC1940 (Candida albicans KCTC1940)는 PDB (potato dextrose broth, Difco) 배지를 사용하여 30℃에서 48시간 배양하였다. 곰팡이의 농도는 1x106 CFU/mL이 되도록 희석하여 96 웰 플레이트 (96 well plate)에 곰팡이 배양액과 연속적으로 희석한 클로렐라 추출액을 혼합하였다. 이들은 30℃에서 48시간 동안 배양한 후 마이크로플레이트 멀티-디텍션 리더(microplate multi-detection reader, Synergy HT, Bioteck, USA)을 이용하여 630 nm에서 측정하였다. The antifungal activity was measured by the liquid growth assay method. Candida albicans KCTC1940 ( Candida albicans KCTC1940) was incubated at 30 ° C. for 48 hours using PDB (potato dextrose broth, Difco) medium. The concentration of the fungus was diluted to 1 × 10 6 CFU / mL, and the 96 well plate (96 well plate) was mixed with the fungal culture solution and serially diluted chlorella extract. They were incubated at 30 ° C. for 48 hours and then measured at 630 nm using a microplate multi-detection reader (Synergy HT, Bioteck, USA).
③ 자유 라디칼 소거력(항산화 효과)의 측정③ Measurement of free radical scavenging power (antioxidant effect)
자유 라디칼 소거력(Free radical scavenging activity)을 측정하기 위하여 DPPH (1,1-diphenyl-2-picrylhydrazyl) 방법을 사용하였다. DPPH 16 mg을 100 mL 에탄올에 녹여서 준비하고 시료 50 μL에 DPPH 저장 용액(stock solution)을 500 μL 넣은 다음 최종 부피(total volume)가 1.0 mL 되도록 에탄올을 첨가하여 실온에서 30분간 반응시킨 후, 분광광도계 (Mecacys, Co. Ltd, Korea) 517 nm에서 측정한다. 표준시료로는 아스코르빈산(ascrobic acid)을 사용하였다. 시료의 흡광도를 (As)로 표준시료의 흡광도를 (Ao)로 하여 항산화 효과를 측정하였다. DPPH (1,1-diphenyl-2-picrylhydrazyl) method was used to measure free radical scavenging activity. After dissolving 16 mg of DPPH in 100 mL of ethanol, 500 μL of DPPH stock solution was added to 50 μL of the sample, followed by reaction for 30 minutes at room temperature by adding ethanol to a total volume of 1.0 mL. Photometer (Mecacys, Co. Ltd, Korea) is measured at 517 nm. Ascorbic acid was used as a standard sample. The antioxidant effect was measured using the absorbance of the sample as (As) and the absorbance of the standard sample as (Ao).
RadicalRadical
ScavengingScavenging
ActivityActivity
( (
RSARSA
, %) = [(,%) = [(
AoAo
--
AsAs
)/) /
AoAo
] X 100]
Ao : 표준시료의 흡광도 Ao : absorbance of standard sample
As : 시료의 흡광도 As : absorbance of the sample
④ 미백효과를 나타내는 티로시나제 저해 활성(Tyrosinase inhibitory activity)④ Tyrosinase inhibitory activity showing whitening effect
티로신(Tyrosine)을 기질로 이용한 티로시나제(tyrosinase) 효소활성의 저해는 Ishihara 등의 방법(J. Invest , Dermatol (1993) 100, 126-131)을 변형하여 실시하였다. 0.1 M 인산염 완충액(pH 6.5) 220 μL, 1.5 mM 티로신 40 μL, 시료용액 20 μL의 혼합용액에 버섯 티로시나제(mushrooum tyrosinase, 1500 U/mL~2000 U/mL)를 20 μL를 첨가하여 37℃에서 10분간 반응시킨 후 96 웰 플레이트에 반응액 200 μL를 넣고, 그 상층액을 마이크로플레이트 멀티-디텍션 리더(Synergy HT, Biotek, USA)을 이용하여 490 nm에서 측정하였다. 표준시료로는 알부틴(albutin)을 사용하였다.Inhibition of tyrosinase enzyme activity using Tyrosine as a substrate was performed by modifying the method of Ishihara et al. ( J. Invest , Dermatol ( 1993) 100 , 126-131). To a mixture of 220 μL of 0.1 M phosphate buffer (pH 6.5), 40 μL of 1.5 mM tyrosine, and 20 μL of sample solution, 20 μL of mushroom tyrosinase (1500 U / mL to 2000 U / mL) was added at 37 ° C. After reacting for 10 minutes, 200 μL of the reaction solution was added to a 96 well plate, and the supernatant was measured at 490 nm using a microplate multi-detection reader (Synergy HT, Biotek, USA). Arbutin was used as a standard sample.
TyrosinaseTyrosinase inhibitioninhibition activityactivity = 100[1-(S-B)/C] = 100 [1- (S-B) / C]
S: Tyrosinase 및 시료액 첨가 시 흡광도 변화값 S: Changes in absorbance when tyrosinase and sample solution were added
B: Tyrosinase 대신 0.1M 인산염완충액 (pH 6.5) 첨가시의 흡광도 변화값 B: Changes in absorbance when 0.1M phosphate buffer (pH 6.5) was added instead of tyrosinase
C: 시료용액 대신 시료를 녹인 용매 첨가시의 흡광도 변화값 C: Absorbance change value when adding a solvent in which a sample is dissolved instead of a sample solution
<5. 클로렐라 비누제조><5. Chlorella Soap Making>
비누베이스를 잘게 썰어서 열을 이용하여 녹인 후 다시 굳기 직전까지 식힌다음 여기에 상기방식으로 유기용매를 이용하여 회수한 클로렐라 추출물(주요성분 : 클로로필 a,b. 베타카로틴 등)을 비누베이스 1Kg당 200ml을 넣고 이를 잘 섞어 준 다음 비누틀을 이용하여 비누를 제조한다.Finely chop the soap base, dissolve it using heat and cool it until it hardens again. Then, extract chlorella extract (main ingredient: chlorophyll a, b. Beta-carotene, etc.) using the organic solvent in the above manner. Put it and mix it well, then prepare soap using a soap mold.
<실시예 1. 추출횟수에 따른 클로로필 피크 면적>Example 1 Chlorophyll Peak Area According to Extraction Frequency
추출한 클로로필(chlorophyll)은 클로로필 (chlorophyll) 표준물질과 비교한 결과, 같은 시간대인 7분대(retention time) 단일 피크(peak)로 깨끗하게 분리되었음을 알 수 있었다(도 1). 클로로필 (chlorophyll) 표준물질과 정량적으로 비교하였을 때, 30%의 클로로필이 함유되어 있음을 알 수 있었다.The extracted chlorophyll was compared to the chlorophyll standard, and as a result, it could be seen that the same time period was cleanly separated into a single peak of 7 minutes (retention time) (FIG. 1). When quantitatively compared with chlorophyll standard, it was found that 30% of chlorophyll was contained.
<실시예 2. 추출된 클로렐라의 유용 성분의 활성 평가><Example 2. Activity Evaluation of Useful Components of Extracted Chlorella>
① 항균 및 항곰팡이 활성① antibacterial and antifungal activity
클로렐라 (Chlorella elliposidea C020) 에탄올 추출물의 항균 및 항곰팡이 에 대한 활성을 최소저해농도 (minimal inhibitory comcentration, MIC)와 최소살균농도 (minimal bacteriocidal concentration, MBC)로 측정하였다. 표 1과 도 3의의 결과를 보면, 그람 양성 박테리아(Gram-positive bacteria)인 바실러스 서브틸리스 PM125 ( Bacillus subtilis PM125)와 바실러스 리케니포르미스 (Bacillus licheniformis )에 대해서만 최소저해농도와 최소살균농도로 125 ㎍/mL에서 활성을 나타내었다. Chlorella elliposidea C020) The antimicrobial and antifungal activity of ethanol extracts was determined by the minimal inhibitory concentration (MIC) and the minimal bacteriocidal concentration (MBC). In the results of Table 1 and Figure 3, Bacillus , Gram-positive bacteria Subtilis PM125 (Bacillus subtilis PM125) and Bacillus Rickenio Formis ( Bacillus licheniformis ) showed activity at 125 ㎍ / mL with minimum inhibitory concentration and minimum bactericidal concentration.
특히, 그람 양성 박테리아인 바실러스 종(Bacillus sp.)에 강한 활성을 나타내었다. 그람 음성 박테리아(Gram-negative bacteria)에서는 어류 병원성 세균인 비브리오 파라헤모리티쿠스 KCTC2471 (Vibrio parahaemolyticus KCTC2471)과 에드워드 타르다 NUF251 (Edward tarda NUF251)에서만 각각 125 ㎍/mL, 250 ㎍/mL에서 활성을 나타내었다. 반면에, 곰팡이인 칸디다 알비칸스(C. albicans)에 대하여서는 활성을 나타내지 않았다.In particular, Bacillus sp., A Gram-positive bacterium, showed strong activity. In Gram-negative bacteria (Gram-negative bacteria) of fish pathogenic bacteria Vibrio para H. Emory Tea Syracuse KCTC2471 (Vibrio parahaemolyticus KCTC2471) and Edward Tarda NUF251 ( Edward Only tarda NUF251) showed activity at 125 μg / mL and 250 μg / mL, respectively. On the other hand, it did not show activity against the fungus C. albicans .
표 1. 클로렐라 추출물의 최소저해농도와 최소살균농도Table 1. Minimum Inhibitory Concentration and Minimum Sterilization Concentration of Chlorella Extract
② 용혈활성 ② hemolytic activity
적혈구 막에 대한 클로렐라(Chlorella elliposidea C020) 에탄올 추출물의 용혈활성을 조사하기 위하여 인간의 적혈구를 사용하였다. 인간의 적혈구에 대한 클로렐라(Chlorella elliposidea C020) 에탄올 추출물 중 가장 높은 농도인 1.0 mg/mL에서도 3% 라는 아주 낮은 활성을 나타내었다. 이러한 결과는 클로렐라 에탄올 추출물이 적혈구에 손상을 주지 않는 좋은 약물의 후보임을 증명하고 있다(도 4).Chlorella on the erythrocyte membrane (Chlorella elliposidea C 020) ethanol Human erythrocytes were used to investigate the hemolytic activity of the extract. Chlorella for human red blood cells (Chlorella elliposidea C020) showed a very low activity of 3% even at 1.0 mg / mL, the highest concentration of ethanol extract. These results demonstrate that chlorella ethanol extract is a good drug candidate that does not damage red blood cells (FIG. 4).
③ 미백효과를 나타내는 티로시나제 저해 활성 ③ Tyrosinase inhibitory activity showing whitening effect
클로렐라 Chlorella elliposidea C020) 에탄올 추출물의 티로시나제 (tyrosinase) 효소활성 저해는 티로신 (tyrosine)을 기질로 이용하여 측정하였다. 클로렐라 에탄올 추출물의 티로시나제 (tyrosinase) 저해 활성 IC50는 10.87 mg/mL로 나타났다 (도 5). 이는 녹차 추출물의 IC50 값 2000 mg/mL 보다 우수한 활성을 나타내었으며, 박태기 나뭇잎 추출물의 IC50 값이 20~50 mg/mL보다도 높은 활성을 나타내었다. 특히, 이전 연구에서 얻은 클로렐라 가수분해 추출물 IC50 값이 120 mg/mL 보다 현저히 높은 활성을 보임을 알 수 있다. 이러한 결과는 클로렐라 에탄올 추출물인 클로로필(chlorophyll)이 우수한 미백 기능성 소재로 사용 가능하며 화장품의 원료로 높은 부가가치를 창출할 후보 물질임이 판명되었다 (도 5).Chlorella Chlorella elliposidea C020) Inhibition of tyrosinase enzyme activity of ethanol extract was measured using tyrosine as a substrate. The tyrosinase inhibitory activity IC 50 of chlorella ethanol extract was found to be 10.87 mg / mL (FIG. 5). It is IC 50 of green tea extract It showed better activity than 2000 mg / mL and IC 50 of the extract of Park Tae-ki leaves. The value showed activity higher than 20-50 mg / mL. Specifically, chlorella hydrolyzed extract IC 50 from previous studies It can be seen that the value shows significantly higher activity than 120 mg / mL. These results proved that Chlorella ethanol extract, chlorophyll, can be used as an excellent whitening functional material and is a candidate material to create high added value as a raw material of cosmetics. (FIG. 5).
<실시예 3. 클로렐라 추출물을 함유하는 미용비누의 효능 테스트><Example 3. Efficacy test of beauty soap containing chlorella extract>
상기 실험방법 5에서 조제된 비누를 10% 수용액으로 제조하고 반창고의 거즈 부분에 충분히 흡수시킨 후 피부 중 연약한 팔의 이두박근에 첩포하여 48시간 후의 피부상태를 점검하였다. 실험대상은 일반인 10명으로 하였고 5단계로 나누어 평가하여 그 점수를 평균하였다. 평가표는 표2에 나타낸 바와 같다. 결과는 평균 0.13으로 거의 피부의 자극이 없는 것으로 평가되었다.Soap prepared in
표 2. 클로렐라 추출물을 함유하는 미용비누의 피부자극 평가표Table 2. Skin irritation evaluation table of cosmetic soap containing chlorella extract
또한 상기 실험방법 5에서 조제된 비누와 대조구로서 시중에서 판매하는 일반 알칼리성 비누를 이용하여 각각 20대 여성 10명씩, 여드름이 있는 남녀 고등학생 10명씩, 아토피가 있는 5~7세 아동 10명씩을 대상으로 30일 동안 아침 저녁으로 세안하게 하고 그 결과를 표 3, 4, 5에 나타내었다.In addition, using the general alkaline soap sold in the market and the soap prepared in
표 3. 20대 여성 피부의 보습력Table 3. Moisturizing Skin of Women in their 20s
본 발명의 클로렐라 미용비누를 사용한 후 80% 이상이 보습력이 향상되어 촉촉한 피부를 유지할 수 있었고, 그에 따라 화장이 잘 받는다고 조사되었다. After using the chlorella beauty soap of the present invention, more than 80% of the moisturizing power was improved to maintain a moist skin, and accordingly it was investigated that the makeup is well received.
표 4. 여드름 피부의 고등학생Table 4. High School Students of Acne Skin
본 발명의 클로렐라 미용비누를 사용한 후 70% 이상이 여드름 피부가 개선되는 것으로 조사되었다.After using the chlorella beauty soap of the present invention, more than 70% of the acne skin was improved.
표 5. 아토피 진정 효과Table 5. Atopy Soothing Effects
본 발명의 클로렐라 미용비누를 사용한 후 90% 이상이 아토피 피부의 진정효과를 경험함으로써 긍정적 반응을 보이는 것으로 조사되었다.More than 90% of the chlorella cosmetic soaps of the present invention were found to have a positive response by experiencing a soothing effect of atopic skin.
도 1은 에탄올을 이용하여 클로렐라로부터 유용성분을 추출하는 과정을 나타내는 그림이다.1 is a diagram showing a process of extracting useful components from chlorella using ethanol.
도 2는 클로렐라로부터 유용성분을 함유하는 추출물의 클로로필 함량을 나타내는 그림이다.Figure 2 is a diagram showing the chlorophyll content of the extract containing useful components from chlorella.
도 3은 클로렐라 에탄올 추출물의 항균활성을 나타낸다. (A) 바실러스 리케니포르미스 (Bacillus licheniformis ), (B) 바실러스 서브틸리스 PM125 ( Bacillus subtilis PM125). (레인 1; 100 mg/mL, 2; 50 mg/mL, 3; 25 mg/mL, 4; 12.5 mg/mL) Figure 3 shows the antimicrobial activity of chlorella ethanol extract. (A) Bacillus Rickenio Formis ( Bacillus licheniformis ), (B) Bacillus Subtilis PM125 (Bacillus subtilis PM125). (Lane 1; 100 mg / mL, 2; 50 mg / mL, 3; 25 mg / mL, 4; 12.5 mg / mL)
도 4는 클로렐라 에탄올 추출물의 용혈활성을 나타낸다.Figure 4 shows the hemolytic activity of chlorella ethanol extract.
도 5는 클로렐라 에탄올 추출물의 미백효과를 나타내는 티로시나제 저해 활성을 나타낸다.Figure 5 shows tyrosinase inhibitory activity showing a whitening effect of chlorella ethanol extract.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080036672A KR100948517B1 (en) | 2008-04-21 | 2008-04-21 | Cosmetic Soap Containing Chlorella Extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080036672A KR100948517B1 (en) | 2008-04-21 | 2008-04-21 | Cosmetic Soap Containing Chlorella Extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090111088A KR20090111088A (en) | 2009-10-26 |
KR100948517B1 true KR100948517B1 (en) | 2010-03-23 |
Family
ID=41538885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080036672A Active KR100948517B1 (en) | 2008-04-21 | 2008-04-21 | Cosmetic Soap Containing Chlorella Extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100948517B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102390656B1 (en) * | 2019-11-13 | 2022-04-27 | (주)진셀팜 | A cosmetic composition comprising chlorella extract for skin-whitening |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3573941B2 (en) * | 1998-02-13 | 2004-10-06 | マイクロアルジェコーポレーション株式会社 | Composition having hyaluronidase inhibitory activity and cosmetic containing the composition |
KR20040084377A (en) * | 2003-03-28 | 2004-10-06 | 학교법인 인제학원 | Cosmetic composition comprising an extract of Chlorella having anti-inflammatory activity |
KR100808630B1 (en) * | 2006-12-28 | 2008-02-29 | 광주과학기술원 | Anti-tumor composition for oral administration containing chlorine compound |
-
2008
- 2008-04-21 KR KR1020080036672A patent/KR100948517B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3573941B2 (en) * | 1998-02-13 | 2004-10-06 | マイクロアルジェコーポレーション株式会社 | Composition having hyaluronidase inhibitory activity and cosmetic containing the composition |
KR20040084377A (en) * | 2003-03-28 | 2004-10-06 | 학교법인 인제학원 | Cosmetic composition comprising an extract of Chlorella having anti-inflammatory activity |
KR100808630B1 (en) * | 2006-12-28 | 2008-02-29 | 광주과학기술원 | Anti-tumor composition for oral administration containing chlorine compound |
Also Published As
Publication number | Publication date |
---|---|
KR20090111088A (en) | 2009-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101494661B1 (en) | Composition for hair or scalp treatment comprising fermented black garlic residue and method of preparing the same | |
KR101253374B1 (en) | Cosmetic composition for controlling anti-acne and anti-comedo | |
KR102065185B1 (en) | Composition for Improving Skin Conditions with Improved Anti-Bacterial, Anti-inflammatory, Anti-wrinkling, and Skin Whitening Property | |
KR102594733B1 (en) | Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof | |
KR101248056B1 (en) | Cosmetic composition for deoderizing odl men smell by using orental natural materials | |
KR102059392B1 (en) | Antimicrobial and Antifungal Composition Containing Clove, Hibiscus, and Coconut Extract Complex as Active Ingredient | |
KR100997452B1 (en) | Cosmetic composition comprising strawberry stem extracts as an effective component | |
KR101020535B1 (en) | Cosmetic composition prepared with soft fermented water | |
KR102700857B1 (en) | Cosmetic composition comprising rosa wichuraiana fermented extract using the ak1954 strain as an effective components | |
KR100948517B1 (en) | Cosmetic Soap Containing Chlorella Extract | |
KR101383519B1 (en) | Composition having excellent antibacterial effect and manufacturing method thereof and cosmetic composition comprising thereof | |
KR102346809B1 (en) | Feminine cleanser containing salt and quercus infectoria oak gall extract | |
KR20200025574A (en) | The Fermented Extract of Rhus Javanica L. with Antioxidant Property, the Cleansing Agent Composition and the Costmetic Composition Containing the Same | |
KR102167319B1 (en) | Composition for Improving Skin Trouble Using an Extract of Coprs Cultured with Magma Seawater, etc. | |
CN106860175A (en) | A kind of inhibiting bacteria and diminishing inflammation mildy wash | |
KR101930409B1 (en) | Detergen composition for prevention of hair loss comprising iceplant as active ingredient | |
KR102452738B1 (en) | A handwash composition containing lactic acid bacteria culture product of cactus flower | |
KR20020069379A (en) | Natural cell control carrier modular compounded Inula Helenium L. extract and water-soluble chitosan | |
KR20070065926A (en) | Composition comprising green tea extract and broccoli extract with antibacterial and deodorant effect as active ingredient and use thereof | |
KR102139000B1 (en) | Antioxidant, anti-wrinkle, whitening and antibiotic cosmetic composition comprising fermented Methyl Sulfonyl methane extract and the preparation method of the same | |
KR20230060310A (en) | Antibacterial and antioxidant composition comprising fermented Centella asiatica extract fermented by inoculating Bacillus safensis strain | |
KR100439868B1 (en) | A compositions for skin external application containing the sap of bamboo | |
KR102507175B1 (en) | Antimicrobial cosmetic composition comprising Salvia Officinalis extract, Caesalpinia Sappan Bark Extract, Houttuynia cordata Extract, Rosmarinus Officinalis Extract, Allium scorodorpasum Extract, and Coptis Chinensis Root Extract as active ingredients | |
KR101207560B1 (en) | Cosmetic composition comprising the extract of Cleyera japonica as active ingredient | |
KR101790250B1 (en) | Soap composition comprising of medicinal plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20080421 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20091218 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20100226 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20100312 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20100315 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20130108 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20130108 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131228 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20131228 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20141224 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20141224 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160108 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20160108 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20161227 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20161227 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180109 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20180109 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190110 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20190110 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20191226 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20191226 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20210216 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20220111 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20230117 Start annual number: 14 End annual number: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20240304 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20250310 Start annual number: 16 End annual number: 16 |